ArticleCureus2025
Patient Selection and Maintenance of Standards to Improve the Safety of Immediate Sequential Bilateral Cataract Surgery in Tropical Regions.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the patient selection and maintain standards to improve the safety of immediate sequential bilateral cataract surgery (ISBCS) in tropical regions that are hot, humid, and prone to infections. MATERIALS AND
methodsThirty-nine participants (78 eyes) meeting stringent inclusion criteria underwent ISBCS. The stricter criteria included absence of systemic disease, absence of ocular abnormalities, and presence of physiological cataract (not traumatic cataract, complicated cataract, pseudoexfoliation, etc.). ISBCS was performed using the phaco-chop technique with a Venturi phaco machine, bimanual irrigation/aspiration, and hydro-implantation of the intraocular lens (IOL). Intraoperative complications (posterior capsule rupture (PCR) and vitreous loss) and postoperative outcomes (corneal edema, toxic anterior segment syndrome (TASS), and endophthalmitis) were monitored. Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and intraocular pressure (IOP) were measured and compared pre- and postoperatively. Statistical analysis was performed, with p < 0.05 considered statistically significant.
resultsNo intraoperative complications (PCR and vitreous loss) were observed. And no postoperative (visual-disturbing corneal edema, TASS, and endophthalmitis) cases were observed. Minimal corneal edema was confirmed with no negative impacts on visual functions. Significant improvements occurred in UCVA and BCVA (p < 0.001), respectively, alongside significant reductions in IOP (p < 0.001).
conclusionStrict patient selection and maintained standards may improve the safety of ISBCS in tropical regions by preventing intraoperative PCR and vitreous loss, as well as postoperative complications such as visual-disturbing corneal edema, TASS, and endophthalmitis. This approach may also facilitate rapid rehabilitation of UCVA and BCVA, maintain corneal stability, and reduce IOP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.